352 filings
8-K
ABIO
ARCA biopharma Inc
23 Apr 24
Departure of Directors or Certain Officers
4:20pm
8-K
ABIO
ARCA biopharma Inc
4 Apr 24
Departure of Directors or Certain Officers
4:30pm
8-K
ABIO
ARCA biopharma Inc
3 Apr 24
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement
7:31am
8-K
ABIO
ARCA biopharma Inc
22 Mar 24
Entry into a Material Definitive Agreement
4:20pm
8-K
ABIO
ARCA biopharma Inc
6 Feb 24
Departure of Directors or Certain Officers
4:15pm
8-K
pj4yxkcwy18fujos
1 Feb 24
ARCA biopharma Announces 2023 Financial Results
4:39pm
8-K
yr9g7p4
31 Jan 24
Departure of Directors or Certain Officers
4:15pm
8-K
ux1nbh1 rb1x0d86wqx
5 Dec 23
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
4:25pm
8-K
ps0ashbenou95jfyg
4 Dec 23
Departure of Directors or Certain Officers
4:36pm
8-K
xowq9 sr6e
18 Oct 23
ARCA biopharma Announces Third Quarter 2023 Financial Results
4:35pm
8-K
5og6bbz 2lv7uiyho4
21 Jul 23
ARCA biopharma Announces Second Quarter 2023 Financial Results
4:35pm
8-K
n3p400t4
24 Apr 23
ARCA biopharma Announces First Quarter 2023 Financial Results
4:35pm
8-K
v8j1 zypiv8bi
24 Feb 23
ARCA biopharma Announces 2022 Financial Results and Provides Corporate Update
4:31pm
8-K
7z8w ayv88e
13 Feb 23
Departure of Directors or Certain Officers
4:30pm
8-K
uca32oy9e0t fpugbpy
19 Dec 22
JaMES FLYNN joins arca biopharma board of directors
4:16pm
8-K
msp82un 01n63cb3x
9 Dec 22
Departure of Directors or Certain Officers
4:15pm
8-K
ij8i1g8tksmp
28 Oct 22
ARCA biopharma Announces Third Quarter 2022 Financial Results
4:25pm
8-K
nkfz7ga
20 Oct 22
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
5:15pm
8-K
xkn0m
2 Aug 22
ARCA biopharma Announces Second Quarter 2022 Financial Results
4:31pm
8-K
4mx vwqzsalm9w4
21 Jun 22
Jacob ma-weaver joins arca biopharma board of DIRECTORS
2:30pm